LAvant Laboratory We Are Vegan
Fatigue is a possible side effect of semaglutide GLP-1 treatment, although it doesnt affect everyone
(Systematic Review, PMC 2025) Is BPC-157 FDA approved
It works by targeting both the GLP-1 and GIP receptors, which regulate appetite, satiety, and insulin sensitivity
Common concerns include: Feeling tired more often than usual Low energy levels Tingling or numbness sensations Difficulty concentrating Weakness These symptoms can have many causes, so speaking with a healthcare provider is the best way to understand your individual situation
For patients whose primary goal is visceral fat reduction, we use Tesamorelin, which is FDA-approved for that specific indication and has stronger clinical data for fat metabolism than sermorelin